Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection

Transplant Proc. 1995 Feb;27(1):854-5.

Authors

S Carl¹, M Wiesel, V Daniel, G Staehler

Affiliation

¹ Department of Urology, University of Heidelberg, Germany.

PMID: 7879205

No abstract available

Publication types

Clinical Trial

MeSH terms

Acute Disease
Adult
Antibodies, Monoclonal / blood
Antibodies, Monoclonal / therapeutic use*
Antigens, CD / blood
Azathioprine / therapeutic use
Combined Modality Therapy
Cyclosporine / therapeutic use
Enzyme-Linked Immunosorbent Assay
Graft Rejection / immunology
Graft Rejection / therapy*
Humans
Immunosuppression Therapy / methods
Kidney Transplantation / immunology*
Methylprednisolone / therapeutic use
Receptors, Interleukin-2 / immunology*
T-Lymphocyte Subsets / immunology

Substances

Antibodies, Monoclonal
Antigens, CD
Receptors, Interleukin-2
Cyclosporine
inolimomab
Azathioprine
Methylprednisolone